IXICO (IXI) Competitors GBX 11.66 -0.35 (-2.88%) As of 09/12/2025 10:49 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock IXI vs. SBTX, HEMO, COS, SAR, C4XD, DDDD, FUM, POLB, AREC, and APTAShould you be buying IXICO stock or one of its competitors? The main competitors of IXICO include SkinBioTherapeutics (SBTX), Hemogenyx Pharmaceuticals (HEMO), Collagen Solutions plc (COS.L) (COS), Sareum (SAR), C4X Discovery (C4XD), 4D pharma (DDDD), Futura Medical (FUM), Poolbeg Pharma (POLB), Arecor Therapeutics (AREC), and Aptamer Group (APTA). These companies are all part of the "biotechnology" industry. IXICO vs. Its Competitors SkinBioTherapeutics Hemogenyx Pharmaceuticals Collagen Solutions plc (COS.L) Sareum C4X Discovery 4D pharma Futura Medical Poolbeg Pharma Arecor Therapeutics Aptamer Group IXICO (LON:IXI) and SkinBioTherapeutics (LON:SBTX) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, institutional ownership, valuation, risk, analyst recommendations, media sentiment, earnings and profitability. Do institutionals and insiders believe in IXI or SBTX? 12.8% of IXICO shares are held by institutional investors. Comparatively, 2.3% of SkinBioTherapeutics shares are held by institutional investors. 6.0% of IXICO shares are held by company insiders. Comparatively, 2.7% of SkinBioTherapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the media favor IXI or SBTX? In the previous week, IXICO had 1 more articles in the media than SkinBioTherapeutics. MarketBeat recorded 1 mentions for IXICO and 0 mentions for SkinBioTherapeutics. IXICO's average media sentiment score of 0.00 equaled SkinBioTherapeutics'average media sentiment score. Company Overall Sentiment IXICO Neutral SkinBioTherapeutics Neutral Which has stronger valuation & earnings, IXI or SBTX? IXICO has higher revenue and earnings than SkinBioTherapeutics. SkinBioTherapeutics is trading at a lower price-to-earnings ratio than IXICO, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIXICO£6.44M1.68-£3.58M-£0.02-500.21SkinBioTherapeutics£2.68M15.87-£3.71M-£0.01-1,314.00 Which has more risk and volatility, IXI or SBTX? IXICO has a beta of 0.86, suggesting that its share price is 14% less volatile than the S&P 500. Comparatively, SkinBioTherapeutics has a beta of 2.01, suggesting that its share price is 101% more volatile than the S&P 500. Is IXI or SBTX more profitable? IXICO has a net margin of -31.10% compared to SkinBioTherapeutics' net margin of -237.95%. IXICO's return on equity of -19.14% beat SkinBioTherapeutics' return on equity.Company Net Margins Return on Equity Return on Assets IXICO-31.10% -19.14% -10.40% SkinBioTherapeutics -237.95%-115.86%-61.18% SummaryIXICO beats SkinBioTherapeutics on 9 of the 12 factors compared between the two stocks. Get IXICO News Delivered to You Automatically Sign up to receive the latest news and ratings for IXI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IXI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IXI vs. The Competition Export to ExcelMetricIXICOBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£10.80M£236.97M£5.86B£2.58BDividend Yield1.27%3.78%5.68%5.30%P/E Ratio-500.2141.0874.865,410.94Price / Sales1.685,000.68517.1296,691.90Price / Cash2.2513.1937.5627.93Price / Book0.60103.7512.157.77Net Income-£3.58M-£90.99M£3.29B£5.89B7 Day Performance-4.03%2.66%0.73%6.51%1 Month Performance-6.61%21.01%4.82%55.94%1 Year Performance22.68%530.89%60.58%147.85% IXICO Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IXIIXICON/AGBX 11.66-2.9%N/A+20.3%£10.80M£6.44M-500.2189News CoverageGap UpSBTXSkinBioTherapeuticsN/AGBX 14.78+0.2%N/A+31.4%£38.25M£2.68M-1,182.4011HEMOHemogenyx PharmaceuticalsN/AGBX 702+17.0%N/A+63,025.0%£32.25MN/A-387.6314Gap DownHigh Trading VolumeCOSCollagen Solutions plc (COS.L)N/AN/AN/AN/A£30.99M£4.01M-8.283,350SARSareumN/AGBX 22.40+1.8%N/A-11.5%£30.33MN/A-861.503,211Gap DownC4XDC4X DiscoveryN/AN/AN/AN/A£30.27M£24.68M300.0049High Trading VolumeDDDD4D pharmaN/AN/AN/AN/A£30.05M£718K-1.08106FUMFutura MedicalN/AGBX 9.26-5.5%N/A-76.0%£28.13M£13.93M2,257.8012POLBPoolbeg PharmaN/AGBX 3.92-0.8%N/AN/A£27.32MN/A-337.7612Gap DownARECArecor TherapeuticsN/AGBX 71.33+1.2%N/A-5.3%£26.93M£5.05M-230.1010Positive NewsAPTAAptamer GroupN/AGBX 0.98-7.1%N/A+358.3%£25.95M£1.22M-348.2137News CoveragePositive NewsInsider Trade Related Companies and Tools Related Companies SBTX Competitors HEMO Competitors COS Competitors SAR Competitors C4XD Competitors DDDD Competitors FUM Competitors POLB Competitors AREC Competitors APTA Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:IXI) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IXICO plc Please log in to your account or sign up in order to add this asset to your watchlist. Share IXICO With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IXI Stock Alerts